Health ❯Healthcare ❯Clinical Trials

Drug Efficacy

Patient Outcomes Leqembi Lecanemab Comparative Studies Cognitive Decline Semaglutide Trials Side Effects Weight Loss Drugs SGLT-2 Inhibitors Vutrisiran COVID-19 Studies Phase Three Trials Lenacapavir Pembrolizumab Kisunla Donanemab Real-World Evidence Obesity Treatments Patient Safety Novo Nordisk Weight Loss Trials Zepbound Semaglutide Study Alzheimer's Treatment Wegovy Study Results Ivermectin Pre-exposure Prophylaxis (PrEP) GLP-1 Receptor Agonists Lecanemab and Donanemab Weight Loss Medications Tirzepatide Study Long-term Effects Lecanemab Trials

Eli Lilly Launches Groundbreaking Weight-Loss Drug Mounjaro in India

EU Drug Agency Recommends Approval of First Alzheimer’s Treatment Targeting Disease Progression

FDA Approves Zepbound as First Medication for Obstructive Sleep Apnea in Adults with Obesity

Novo Nordisk Shares Plunge After Weight-Loss Drug Trial Falls Short

Experts Explore Potential of Ozempic Microdosing for Health Beyond Weight Loss

Zepbound Outperforms Wegovy in Weight Loss Clinical Trial

First New Asthma and COPD Treatment in 50 Years Shows Promise

EMA Approves Lecanemab for Early-Stage Alzheimer’s Treatment in EU

UK Regulators Warn Against Misuse of Weight-Loss Injections

Oxford Study Identifies Most Effective Migraine Treatments

Lenacapavir Injection Shows 96% Efficacy in Preventing HIV

Alnylam's Vutrisiran Shows Mixed Results in Cardiomyopathy Study

Type 2 Diabetes Drug Shows Potential to Lower Dementia Risk by 35%

NHS Declines Coverage for Groundbreaking Alzheimer's Drug Due to High Costs

Weight-Loss Drugs Reshape Health and Consumer Markets

UK Approves Wegovy for Reducing Heart Risks in Overweight Patients